IceCure Medical Ltd. recently announced the FDA Medical Device Advisory Committee Panel’s favorable recommendation (voti ...

Robert L. Minor Jr, MD Interventional Cardiologist and Endovascular Specialist Director of Endovascular Interventions Limb ...

Opportunities to improve or optimize radial access for peripheral artery disease and embolization include additions and ...

When I was invited by Endovascular Today to serve as Guest Chief Medical Editor of an edition on aortic dissection (AD), I ...

Dr. Melissa Russo discusses contributing factors, an approach to diagnosing aortic dissection in the pregnant patient, an algorithm for management, common misconceptions, and counseling and ...

Bentley InnoMed GmbH announced it has been granted two TÜV certificates that extend indications for its stents in complex ...

Healionics Corporation announced that its Stargraft arteriovenous (AV) graft for dialysis access has been granted ...

Simcere Pharmaceuticals Group Ltd. recently announced that findings from the TASTE-2 clinical study have shown that the admini ...

Arsenal Medical announced the initiation of the EMBO-02 clinical study of its NeoCast liquid embolic to treat chronic ...

November 20, 2024—enVVeno Medical Corporation announced 1-year data on all patients from SAVVE, the United States pivotal trial of the company&r ...

November 11, 2024—iVascular announced the initiation of OPAL, a first-in-human study of Amber, the company’s embolic liquid ...

Aortic dissections are classified by site (Stanford type A, ascending aorta; type B, descending aorta) and chronicity (acute if onset of symptoms 2 weeks, chronic if > 2 weeks). The acute group can ...